Jens Schwamborn and his company OrganoTherapeutics is using their technology (human-specific mini-brains) to treat Parkinson's. He walks Marshall through how they grew their young company through the time of a global pandemic and the opportunities they made from it to use their technology to support research in therapies related to SARS COV 2.
OrganoTherapuetics is a SLAS2021 New Product Award winner and an participated in Innovation AveNEW at SLAS2021 Digital.
SLAS2026 International Conference & Exhibition
SLAS Europe 2026 Conference and Exhibition
